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Abstract
 
Not all T cells specific for autoantigens are eliminated in the thymus, and therefore alternate
mechanisms are required to prevent potentially autoreactive T cells from developing into effec-
tors. Adoptive transfer of CD8
 
 
 
 T cells from influenza hemagglutinin-specific Clone 4 TCR
transgenic mice into mice that express hemagluttinin in the pancreatic islets results in tolerance.
This is preceded by activation of Clone 4 T cells that encounter antigen cross-presented in the
draining lymph nodes of the pancreas. In this report we compare the phenotype, function, and
costimulatory requirements of Clone 4 T cells activated by endogenous self-antigen, with
Clone 4 T cells stimulated by influenza virus. The cells undergoing tolerance upregulate both
CD69 and CD44, yet only partially downregulate CD62L, and do not express CD49d or
CD25. Most importantly, they lack the ability to produce interferon-
 
 
 
 in response to antigen
and show no cytolytic activity. Clone 4 T cells disappear after several cycles of division, appar-
ently without leaving the site of initial activation. Surprisingly, despite the fact that such stimu-
lation occurs through recognition of antigen that is cross-presented by a professional antigen-
presenting cell, we find this activation is not dependent on costimulation through CD28.
These data demonstrate that the recognition by naive CD8
 
 
 
 T cells of cross-presented self-
antigen results in localized proliferation and deletion, without the production of effector cells.
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Introduction
 
Negative selection in the thymus is arguably the major
mechanism of T cell tolerance (1, 2). However, as many
peripherally expressed antigens are not present in the thy-
mus at a level sufficient to eliminate all cognate T cells,
there exist additional mechanisms in the periphery that pre-
vent autoimmunity. One such mechanism involves periph-
eral deletion of CD8
 
 
 
 T cells activated through recogni-
tion of self-antigen that is picked up, processed, and
presented by APCs (3). These APCs are presumed to be
dendritic cells, as these have been shown to be unique in
their ability to acquire antigen in the parenchyma, and
present it to naive T cells in the draining LNs (4, 5). De-
spite the fact the T cells are activated and undergo prolifer-
ation, this encounter results in tolerance rather than au-
toimmunity (3, 6–8). The nature of the tolerizing signals is
poorly understood, however, in all models in which this
occurs, T cells recognize antigen that is presented in a non-
inflammatory environment.
Our laboratory has been studying such peripheral toler-
ance in InsHA mice that express the hemagglutinin (HA)
 
*
 
protein from the influenza virus under the control of the
rat insulin promoter (9). These mice are tolerant of HA
that is expressed on the 
 
 
 
 cells of the pancreatic islets, such
that the TCR repertoire is purged of T cells with high
avidity for HA (9–11). We have demonstrated previously
that HA-specific CD8
 
 
 
 T cells become tolerant after they
leave the thymus (9, 12). To study the mechanism of toler-
ance induction in InsHA mice, we produced Clone 4
TCR transgenic mice that express a relatively high affinity
TCR specific for the major K
 
d
 
-restricted HA epitope (12).
This receptor was obtained from a B10.D2 animal that was
immunized with influenza. Upon transfer of naive Clone 4
CD8
 
 
 
 T cells into InsHA recipients, the T cells become
activated and proliferate in the draining LNs of the pan-
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creas (8). The activated Clone 4 T cells did not cause dia-
betes and were either deleted or inactivated (8, 13). To
learn more about the basis for this apparent paradox, in
which activation of CD8
 
 
 
 T cells is benign to the host and
results in clonal elimination or inactivation, we have inves-
tigated the phenotype and functional capability of the
Clone 4 CD8
 
 
 
 T cells that proliferate in the pancreatic
LNs of InsHA mice.
 
Materials and Methods
 
Mice.
 
Balb/c mice were purchased from the breeding colony
of The Scripps Research Institute. InsHA transgenic mice (9),
homozygous for the HA gene, had been backcrossed with Balb/c
at least eight generations. Clone 4 TCR transgenic mice (12)
were also backcrossed with Balb/c mice for at least eight genera-
tions and were then crossed with Balb/c Thy1.1
 
 
 
/
 
 
 
 for two gen-
erations to achieve homozygosity for Thy1.1. Mice were propa-
gated and maintained under specific pathogen-free conditions in
The Scripps Research Institute’s animal facility. All mice used in
these studies were between 8 and 12 wk of age. Experimental
procedures were performed according to the National Institutes
of Health Guide for Care and Use of Laboratory Animals.
 
Preparation of CFSE-labeled Clone 4 CD8
 
 
 
 T Cells.
 
CD8
 
 
 
Thy1.1
 
 
 
 T cells from Clone 4 TCR were prepared as described
previously (8, 13) with certain modifications. Single cell suspen-
sions were prepared from spleen and LNs of Clone 4 TCR trans-
genic mice and RBCs were lysed. Cells were then passed through
a nylon wool column (Wako Chemicals) according to manufac-
turer’s instructions. Nonadherent cells were incubated for 1 h at
4
 
 
 
C with anti-CD4 (clone RL172) mAb, in the form of tissue
culture supernatant, at a concentration of 10
 
7
 
 cells per milliliter.
After centrifugation, Low-Tox rabbit complement (Accurate
Chemical) was added to a final dilution of 10% in RPMI 1640
medium and cells were further incubated for 1 h at 37
 
 
 
C. Cells
were finally washed with RPMI containing 10% FCS. 5
 
   
 
10
 
7
 
purified CD8
 
 
 
 T cells were incubated in 1 ml of 5 
 
 
 
M 5- and
6-carboxy-fluorescein succinimidyl ester (CFSE; Molecular
Probes) in HBSS for 10 min at 37
 
 
 
C. Cells were then washed
with ice-cold HBSS.
 
Adoptive Transfer, Immunization, and Ab Treatment.
 
Recipient
InsHA or Balb/c mice were injected intravenously with 3
 
   
 
10
 
6
 
CFSE-labeled Clone 4 TCR CD8
 
 
 
 T cells in 200 
 
 
 
l of HBSS on
day 0. Immediately after transfer, groups of mice were immunized
intraperitoneally with 500 HA U of influenza virus A/PR/8/34
H1N1 that was grown in the allantoic cavity of 10-d-old hen’s
eggs. Mice immunized with a low dose of influenza virus received
12 HA U. Mice immunized with the K
 
d
 
 HA peptide (IYS-
TVASSL) received 100 
 
 
 
g of peptide in PBS intravenously.
In some experiments mice were treated with a combination of
purified anti-B7.1 (clone 16-10A1; American Type Culture Col-
lection[ATCC]) plus anti-B7.2 (clone GL1; ATCC) mAbs; 100
 
 
 
g of each Ab per mouse per dose. Groups of mice treated with
purified hamster IgG plus rat IgG (Jackson ImmunoResearch Lab-
oratories) served as isotype controls. Abs were administered intra-
peritoneally in HBSS on days 0, 1, 2, 3, and in some cases on day 5.
Mice were monitored for diabetes by measuring blood glucose on
days 4, 6, 8, and every 4 d thereafter. They were considered dia-
betic when glucose levels were
 
  
 
300 mg/dl.
 
Flow Cytometry.
 
4 or 8 d after receiving CFSE-labeled cells,
pancreatic LNs and a mixture of other LNs including inguinal,
axillary, cervical, and mandibular were excised and processed sep-
arately to obtain single cell suspensions. After counting, all the
cells from the pancreatic LNs and an equivalent number of cells
from the other LNs were stained with the indicated Abs. LNs
from three mice receiving the same treatment were pooled to-
gether for staining.
All mAbs and secondary reagents were purchased from BD
PharMingen. Donor Clone 4 T cells were detected and enumer-
ated by virtue of their Thy1.1 expression. LN cells were incu-
bated with anti-CD8
 
 
 
-PerCP and anti-Thy1.1-PE mAbs in
HBSS, 0.1% BSA, 0.02% sodium azide for 30 min at 4
 
 
 
C. After
washing, cells were analyzed with a FACSCalibur™ apparatus
using CELLQuest™ software (Becton Dickinson). In analyzing
each sample, 1.5
 
   
 
10
 
6
 
 events were collected. The intensity of
CFSE fluorescence was analyzed in the CD8
 
 
 
 Thy1.1
 
 
 
 subpopu-
lation of lymphocytes.
For the phenotypic characterization of dividing Clone 4
CD8
 
 
 
 T cells, pancreatic LN cells were previously incubated
with either biotin-labeled anti-CD25, anti-CD44, anti-CD69,
anti-CD49d, or anti-CD62L mAbs for 30 min at 4°C, washed,
and incubated again with a mixture of streptavidin-APC, anti-
CD8
 
 
 
–PerCP, and anti-Thy1.1–PE mAbs for 30 min at 4
 
 
 
C.
Biotin-labeled annexin V was used for the detection of apop-
totic Clone 4 cells. In this case incubation times were reduced to
15 min and performed at room temperature in annexin V bind-
ing buffer (BD PharMingen).
To assess production of IFN-
 
 
 
 in response to antigen, LN cells
were incubated in RPMI 1640 10% FCS with 1 
 
 
 
g/ml of the K
 
d
 
HA peptide and 1 
 
 
 
l/ml of Brefeldin A containing Golgi-Plug
solution (BD PharMingen) for 6 h at 37
 
 
 
C. An irrelevant peptide
was used instead of the K
 
d
 
 HA peptide as a negative control. Af-
ter washing cells were stained to detect cell surface CD8 and
Thy1.1 as described previously. Cells were then permeabilized
and stained to detect intracellular IFN-
 
 
 
 with anti-IFN-
 
 
 
-APC
mAb using the Cytofix/Cytoperm Plus kit (BD PharMingen) ac-
cording to manufacturer’s instructions.
 
In Vivo Cytotoxicity Assay.
 
Mice were injected with 3
 
   
 
10
 
6
 
nonlabeled, purified Clone 4 CD8
 
 
 
 T cells. Syngenic spleen cells
were labeled by incubation for 15 min at 37
 
 
 
C with either 5 
 
 
 
M
CFSE in HBSS (CFSE
 
high
 
 cells) or 0.5 
 
 
 
M CFSE in HBSS (CF-
SE
 
low
 
 cells) and washed twice with HBSS. CFSE
 
high
 
 cells were
pulsed with K
 
d
 
 HA peptide at 1 
 
 
 
g/ml for 1 h at 37
 
 
 
C. CFSE
 
low
 
cells were not pulsed and served as an internal control. On day 4
mice were injected intravenously with a mixture of 2.5
 
   
 
10
 
6
 
CFSE
 
high
 
 peptide-pulsed cells plus 2.5
 
   
 
10
 
6
 
 CFSE
 
low
 
 nonpulsed
cells. Pancreatic LNs were excised 10 h later and single cell sus-
pensions were analyzed for detection and quantification of
CFSE-labeled cells.
 
Results
 
The Fate of Clone 4 CD8
 
 
 
 T Cells in InsHA Mice.
 
We
have previously demonstrated that CSFE-labeled Clone 4
CD8
 
 
 
 T cells adoptively transferred into InsHA mice be-
come activated and proliferate in the pancreatic LNs, but
not elsewhere in the host (8). This activation was a prereq-
uisite for tolerance induction of the Clone 4 cells. In this
model, the rate of T cell activation, and consequently, the
rate of tolerance induction is limited by the amount of anti-
gen made available for stimulation through cross-presenta-
tion (13). To more carefully examine the fate of Clone 4
cells as they undergo tolerance in InsHA mice, we have ex-
tended those studies by tracking the T cells at later time 
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points after adoptive transfer (Fig 1). We have also com-
pared the consequence of activation of Clone 4 cells by en-
dogenous HA, which results in tolerance, with activation
by influenza virus, which results in insulitis and diabetes in
InsHA mice (13).
Clone 4 CD8
 
 
 
 T cells do not proliferate when trans-
ferred into syngenic Balb/c hosts that lack expression of
HA (Fig. 1 A). However, by day 8 after transfer some cells
were detected that had undergone a single cycle of division
(Fig. 1 A). This is most likely due to homeostatic prolifera-
tion. The total number of Clone 4 cells present in the pan-
creatic LNs of Balb/c recipients is similar at 4 or 8 d after
transfer (Fig. 1 B). In InsHA recipients, proliferation driven
by cross-presentation of endogenous antigen is detectable
in the pancreatic LNs but not in other LNs at days 4 and 8.
The number of division cycles and the numbers of prolifer-
ating cells within each peak are similar on days 4 or 8.
However, the peak corresponding to undivided cells is re-
duced by half during this time period (note change in
scale), indicating a gradual consumption of the naive cells
(Fig. 1 A). There was no evidence for increased numbers of
activated cells. Also, by counting the total numbers of
Clone 4 cells in the pancreatic LNs we could not detect ac-
cumulation over time (Fig. 1 B), despite evidence of prolif-
eration. Indeed, a slight but significant decrease in total
number of Clone 4 cells was evident between days 4 and 8.
Of interest, the proliferating cells did not migrate from the
pancreatic LNs to appear at different locations in the lym-
phoid system (Fig. 1 A). Taken together, these data indi-
cate that only a small proportion of the T cells are stimu-
lated at any given point in time, and that the activated cells
do not accumulate within the lymphoid tissue.
This observation raised the question of what happens to
the cells that divided previously. One possible explanation
is that these activated HA-specific T cells had migrated to
the pancreas where there is expression of cognate antigen.
However, immunohistochemical examination of the pan-
creas indicated no such infiltration (data not shown). An al-
ternative possibility, and one that is consistent with the fact
the cells become tolerized in InsHA mice (8, 13), is that the
cells are both proliferating and dying within the pancreatic
LNs. To determine if this was the case, annexin V staining
was performed to detect apoptotic cells in the pancreatic
LNs of InsHA mice (Fig. 2). On day 4, an average of 7% of
all Clone 4 CD8
 
 
 
 T cells were annexin V positive, indicat-
ing an early stage in apoptosis, while 
 
 
 
1% of the Clone 4
cells in Balb/c hosts were found to be positive. Taken to-
gether, these data suggest that the Clone 4 CD8
 
 
 
 T cells
slowly become activated and die within the lymphoid tis-
sue of InsHA mice.
In parallel experiments, we examined the fate of the
Clone 4 cells in InsHA mice that were infected with influ-
Figure 1. Clone 4 CD8  T cells proliferate in the
pancreatic LNs of InsHA mice but do not accumulate
over time. 3   106 CFSE-labeled, purified, Thy1.1 
Clone 4 CD8  T cells were injected into either
Balb/c or InsHA hosts. Injected InsHA mice were
split into two groups, one was immunized with influ-
enza virus at the time of transfer and the other was
left untreated. Mice were killed on days 4 or 8 after
transfer and cells from pooled LNs were analyzed by
FACS®. (A) Histograms represent the amount of
CFSE label gating on CD8  Thy1.1  lymphocytes.
This experiment has been repeated five times for InsHA
mice and three times for influenza immunized InsHA
and Balb/c mice. (B) Total numbers of CD8  Thy1.1  cells in the pancreatic LNs of host mice. Data represent the mean of all independent experiments
performed. Only negative standard deviation is depicted to achieve greater sensitivity in the graph. 
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enza. On day 4 after the InsHA mice received both Clone
4 CD8
 
 
 
 T cells and influenza, there was vigorous activa-
tion and proliferation, with a clear accumulation of cells in
the pancreatic LNs as well as other LNs. By day 8, the
numbers of Clone 4 cells had dramatically declined in the
lymphoid tissue (Fig. 1 A, note change in scale from days
4–8). This was clearly reflected in the decrease in the total
number of Clone 4 CD8
 
 
 
 T cells recovered from the pan-
creatic LNs (Fig. 1 B). Of interest, when stained with an-
nexin V on day 4, there was evidence that many of the
virus-stimulated T cells, an average of 
 
 
 
40%, were under-
going apoptosis beginning after 4 cycles of division. Pre-
sumably this represents activation-induced cell death (Fig.
2). These mice developed diabetes by days 6–8, due to the
migration of activated Clone 4 CD8
 
 
 
 T cells to the pan-
creatic islets (data not shown).
 
Clone 4 CD8
 
 
 
 T Cells Responding to Endogenous Antigen
Display a Distinctive Phenotype.
 
In an effort to understand
the basis for the different fate of the Clone 4 cells, depend-
ing upon whether they were activated through encounter
with self-antigen or virus infection, we analyzed the Clone
4 CD8
 
 
 
 T cells, obtained at day 4 from the pancreatic LNs
of InsHA mice, for their expression of key activation mark-
ers (Fig. 3). Naive CD8
 
 
 
 T cells, like the Clone 4 cells
transferred into Balb/c hosts, are characterized by a CD25
 
 
 
,
CD69
 
low
 
, CD44
 
low
 
, CD62L
 
high
 
, CD49d
 
low
 
 phenotype (Fig.
3; reference 14). In contrast, T cells activated by influenza
virus proliferated vigorously and the expression pattern of
these molecules switched to that characteristic of effector
CD8
 
 
 
 T cells. They became CD25
 
 
 
, CD69
 
high
 
, CD44
 
high
 
,
CD62L
 
low
 
, CD49d
 
high
 
 (Fig. 3). Some of these changes re-
quired that cells first undergo several rounds of division be-
fore they achieved the full activation phenotype. For exam-
ple, maximal levels of expression of VLA-4 (CD49d) and
IL-2R
 
 
 
 (CD25) did not occur until division cycle 5 or 6
(Fig. 3 B). However, the cells exhibited a gradual increase
in expression that could be seen in earlier divisions.
In contrast, Clone 4 CD8
 
 
 
 T cells that were activated to
proliferate in response to self-antigen in the InsHA mice
demonstrated a different phenotype. Although an early ac-
tivation marker, CD44, became efficiently upregulated
soon after the first round of division, there was no upregu-
lation of CD25 or CD49d, and less downregulation of
CD62L. Also, even though the expression pattern of CD69
was similar to that of Clone 4 cells taken from influenza in-
fected mice, the maximum levels reached by each cell pop-
ulation was clearly different (Fig. 3 B). Thus, clear differ-
ences in cell surface expression of activation markers were
exhibited by the Clone 4 cells depending upon whether
they were stimulated with endogenous antigen or virus.
 
Clone 4 CD8
 
 
 
 T Cells Proliferating in Response to Endoge-
nous Antigen Do Not Develop Effector Function.
 
The obser-
vation that Clone 4 CD8
 
 
 
 T cells stimulated by endoge-
nous self-antigen did not express a “classical” effector CTL
phenotype led us to question whether the activated cells
demonstrated effector function. Production of IFN-  in
response to antigen represents an early effector function.
Indeed, a total of  60% of the Clone 4 cells obtained from
influenza-infected mice exhibited the ability to produce
IFN-  at day 4 after transfer (Fig. 4). This cytokine was
clearly detected even in cells that had divided only once or
twice (Fig. 4). In contrast, the Clone 4 T cells taken from
the pancreatic LNs of InsHA mice did not produce IFN- 
at day 4 after transfer (Fig. 4). Due to the limiting amount
of cross-presented antigen few of the Clone 4 T cells trans-
ferred into InsHA are activated and proliferate at any given
time. This is an ongoing process that continues until all na-
ive Clone 4 cells are tolerized (13). Therefore, the cells that
have experienced fewer rounds of division are likely to be
derived from naive cells that were more recently activated.
Figure 2. Detection of apoptotic Clone 4
CD8  T cells. CFSE-labeled, purified, Thy1.1 
Clone 4 CD8  T cells were injected into the
indicated hosts as in Fig. 1. On day 4 after
transfer mice were killed and cells from pooled
pancreatic LNs were analyzed by FACS® to de-
tect apoptotic cells through annexin V binding.
(A) Plots represent the amount of CFSE label
versus annexin V binding–intensity gating on
lymphocytes CD8  Thy1.1 . One representa-
tive experiment out three independent experi-
ments is shown. (B) Percentage of Clone 4
Thy1.1  CD8  T cells that are annexin V  in
the pancreatic LNs of recipient mice. Data rep-
resent the mean of three independent experi-
ments performed.711 Hernandez et al.
Accordingly, these data argues against the possibility that
cells undergoing tolerance may produce IFN-  at an early
stage in division. In addition, examination of the Clone 4
cells taken from InsHA mice at day 2 after transfer, a time
point when they have only divided one or two times, also
showed no production of IFN-  (data not shown).
Next, we compared the ability of the Clone 4 T acti-
vated by either endogenous antigen or influenza virus, to
lyse target cells that were pulsed with the HA peptide (Fig.
5). Peptide pulsed and nonpulsed spleen cells that were dif-
ferentially labeled with different concentrations of CFSE
were injected into InsHA or Balb/c mice that had received
Clone 4 T cells 4 d earlier. After 10 h, cells from the pan-
creatic LNs were examined for evidence of lysis of targets
pulsed with the HA peptide antigen. In Balb/c mice which
received Clone 4 cells, a slight reduction was observed in
the peak of CFSEhigh peptide pulsed targets, relative to the
internal control of CFSElow cells that had not been pulsed
with peptide (ratio CFSElow/CFSEhigh   1.2   0.1; Fig. 5).
Essentially identical results were found when Clone 4 cells
were injected into InsHA mice (ratio CFSElow/CFSEhigh  
1.3   0.1; Fig. 5). This small reduction observed in the
CFSEhigh peptide pulsed cells may be attributable to activa-
tion of naive, undivided Clone 4 cells by the CFSE targets,
as it was not observed in mice that had not received Clone
4 cells (ratio   1.0 in both Balb/c and InsHA). In contrast,
cytolytic activity was clearly evident in recipients that had
been infected on day 0 with influenza (ratio CFSElow/
CFSEhigh   18   9; Fig. 5). These data indicate that acti-
vation of Clone 4 cells by endogenous HA alone did not
result in cytolytic activity.
In the experiments described above, influenza virus–
immunized mice received a high dose of virus (500 HA U).
In this situation, the amount of antigen available to Clone
4 cells is much higher than when the only source of Kd HA
peptide is the pancreatic HA protein. This is readily appre-
ciated by comparing the number of cells that remained un-
divided in both situations (Fig. 1 A). Such a difference in
antigen load could be responsible for the differential po-
tential of Clone 4 cells of gaining effector function. To ad-
Figure 3. Phenotypic characterization of proliferating Clone 4 CD8  T cells. CFSE-labeled, purified, Thy1.1  Clone 4 CD8  T cells were injected
into different hosts as in Fig. 1. On day 4 after transfer mice were killed and cells from pooled pancreatic LNs were analyzed by FACS® to detect expres-
sion of key activation surface markers. (A) Plots represent the amount of CFSE label versus the intensity of expression of five different activation markers
gating on lymphocytes CD8  Thy1.1 . One out of two independent experiments with similar results is shown. (B) Representation of the geometrical
mean fluorescence intensity (GMFI) of the different activation markers from A examined as a function of the division cycles. GMFI was selected for this
analysis due to the small numbers of cells involved in the analysis of each cycle of division, particularly in the case of Clone 4 T cells activated by endog-
enous expression of HA.712 Analysis of CD8  T Cells Undergoing Peripheral Deletion
dress this issue we decreased the amount of virus used for
immunization to achieve conditions in which only a small
percentage of the transferred cells divided (Fig. 6 A). Balb/c
mice were used in these experiments to avoid interfer-
ence with the endogenous antigen. Clone 4 cells stimu-
lated by this “low dose” of virus (12 HA U), however, di-
vided more that seven times and were able to efficiently
secrete IFN-  (Fig. 6 A). As another approach, we looked
at IFN-  production by Clone 4 T cells in a situation in
which tolerance occurs after infusion of a high dose of
peptide antigen. Systemic injection of 100  g of soluble Kd
HA peptide after adoptive transfer of Clone 4 CD8  T
cells induces a dramatic expansion of these cells followed
by a rapid deletion without development of diabetes in
Figure 4. IFN-  production by proliferating Clone 4 CD8  T
cells. 3   106 CFSE-labeled, purified, Thy1.1  Clone 4 CD8  T cells
were injected into InsHA recipients that were either immunized with
influenza virus or left untreated. On day 4 after transfer cells from
pooled pancreatic LNs were incubated with Kd HA peptide (stimu-
lated) or an irrelevant peptide (nonstimulated) for 6 h at 37 C. Then,
cells were analyzed by FACS® to detect accumulation of intracellular
IFN- . (A) Plots represent the amount of CFSE label versus the inten-
sity of IFN-  produced gating on lymphocytes CD8  Thy1.1 . Data
correspond to one out of two independent experiments with similar
results. (B) Representation of the percentage of CD8  Thy1.1  T
cells that are IFN-   from A as a function of the division cycle.
Figure 5. In vivo  cytolytic
activity of proliferating Clone 4
CD8  T cells. 3   106 purified
Clone 4 CD8  T cells were in-
jected into either Balb/c or InsHA
hosts. Injected InsHA mice were
split into two groups, one was
immunized with influenza virus
at the time of transfer and the
other was left untreated. 4 d af-
ter transfer mice were injected
with a mixture of 2.5    106
CFSEhigh-labeled, Kd HA pep-
tide pulsed syngenic spleen cells,
and 2.5   106 CFSElow-labeled,
nonpulsed cells, as targets.
Groups of mice that did not re-
ceive Clone 4 cells were used as
controls and were also given
CFSE-labeled target cells. 10 h
later lymphocytes from the pan-
creatic LNs of four individual
mice per group (n    4) were
examined by FACS® to detect and quantify CFSE-labeled cells. Histograms represent the amount of CFSE label of one representative mouse per
group. The mean   SD of the ratio of the number of CFSElow/CFSEhigh cells (r) for all mice in each group is indicated. Data represent one out of two
experiments with similar results.713 Hernandez et al.
InsHA mice (unpublished data). Clone 4 cells proliferating
in Balb/c mice in response to soluble peptide did not pro-
duce IFN-  (Fig. 6 B). Taking together, our results indi-
cate that the development of effector function is not re-
lated to the antigen dose but rather to the context in which
antigen is recognized.
Proliferation of Clone 4 CD8  T Cells in the Pancreatic LNs
Occurs Independent of Costimulation by B7.1 7.2. The im-
portant role of costimulation through CD28 in the devel-
opment of a CD8  T cell response is well established (for a
review, see references 15–17). This occurs when T cells are
stimulated by APCs that express B7.1/7.2 molecules.
However, the absence or presence of this type of costimu-
lation in the induction of T cell tolerance in vivo is still
controversial and varies enormously depending on the sys-
tem under examination (18, 19). The role of costimulation
in tolerance resulting from cross-presentation of self-anti-
gen has not been addressed previously. To determine
whether such costimulation was required for activation of
Clone 4 T cells in response to endogenous self-antigen, we
examined the effect of anti-B7 blocking mAbs. Anti-B7.1
mAb 16-10A1 and anti-B7.2 mAb GL1 have been used
successfully to block CD28/B7 interactions (20). In vitro, a
combination of both Abs was able to block the develop-
ment of Clone 4 cells into effector CTLs and substantially
reduced their proliferative potential in response to influ-
enza virus–infected cells (data not shown). Individually,
these Abs blocked neither proliferation nor CTL function.
Surprisingly, when administered to InsHA mice, the
amount of activation and proliferation of Clone 4 T cells in
response to endogenous HA was found to be similar in the
presence and absence of anti-B7 mAbs (Fig. 7 A). The
number of division cycles observed and the percentage of
cells within each cycle were almost identical. Also, the total
numbers of Clone 4 cells in the pancreatic LNs were iden-
tical in both situations (Fig. 7 B). In contrast, these reagents
had a profound effect on expansion of Clone 4 CD8  T
cells stimulated by influenza virus (Fig. 7, A and B). A four-
fold lower number of cells were recovered from the pan-
creatic LNs of virus-infected mice that received these Abs,
and the CD8 cells that were recovered expressed threefold
less IFN-  (Fig. 7 C) and did not induce diabetes.
Discussion
Cross-presentation by APCs of exogenous antigen leads
to the activation of naive, antigen-specific T cells in the pe-
riphery. In the presence of inflammatory agents, such as
pathogens, activation results in the development of a vigor-
ous T cell response. However, in the case of cross-presen-
tation of self-antigens, activation results in tolerance induc-
tion (for a review, see reference 21). The current study
represents the first detailed analysis of the phenotypic char-
acteristics, functional capabilities, and costimulation require-
ments of T cells that are tolerized specifically by cross-pre-
sentation of self-antigen. Although others have previously
studied some of these characteristics in T cells undergoing
in vivo peripheral tolerance in response to exogenously
provided or ubiquitously expressed antigens (22–25) in
each of these situations, multiple cell types are involved in
antigen presentation. The current study has examined tol-
erance as it occurs to an antigen expressed in the pancreatic
islets via cross-presentation of antigen by a professional
APCs. We have contrasted the phenotype and effector
function of naive Clone 4 TCR cells that are activated in
vivo either by cross-presentation of an endogenously ex-
pressed antigen, or by infection with influenza virus. The
signals delivered in the former situation induce a partial ac-
tivation program in which the HA-specific CD8  T cells
acquire a limited proliferation potential and display a dis-
tinctive phenotype, CD44high, CD69intermediate, CD25 ,
CD62Lintermediate, CD49d low. Moreover, they do not de-
velop a key early effector function, the production of IFN- ,
and do not lyse HA-pulsed targets in vivo.
Figure 6. IFN-  production
by proliferating Clone 4 CD8 
T cells is not dependent on the
antigen dose. 3   106 CFSE-
labeled, purified, Thy1.1  Clone
4 CD8  T cells were injected
into Balb/c recipients. Cells re-
covered from the pancreatic LNs
were analyzed for their ability to
produce IFN-  as described in
Fig. 4. (A) Mice were immu-
nized with 12 HA U of influenza
virus at the time of cell transfer
and killed on day 4. (B) Mice
were immunized with 100  g of
Kd HA peptide intravenously at
the time of cell transfer and
killed on day 3.714 Analysis of CD8  T Cells Undergoing Peripheral Deletion
A number of studies have concluded that there is a
strong link between the number of cell divisions by acti-
vated T cells, and the expression of activation markers and
cytokines (26–28). Although there is a marked difference in
the proliferative potential of Clone 4 cells that are stimu-
lated by cross-presentation of self-antigen as compared with
influenza infection, some of the differences observed in
phenotype and function appear to be related to the quality
of the signals received rather than the fact that they un-
dergo fewer division cycles. Clone 4 cells obtained from
virus infected mice demonstrate downregulation of CD62L
after a single division cycle. Upregulation of CD25 and
CD49d is noticeable after the second division, as is the abil-
ity to produce IFN- . In contrast, although we can detect
cells that have undergone up to five division cycles in re-
sponse to endogenous self-antigen, in the case of expression
of CD25, CD49d, and IFN- , these activation and effector
markers were not evident. It has also been proposed that
gain of effector function and activation markers in T cells
correlates with proliferative capacity and is independent of
the signals inducing proliferation in vivo (27). In this previ-
ous study it was observed that CD4  T cells which under-
went division as a consequence of stimulation through
TCR alone (in the absence of costimulation) expressed the
same phenotype as cells that received stimulation through
both TCR and CD28, as long as they underwent compara-
ble numbers of divisions. The differences between the pre-
vious findings and the current study is unclear, but may be
related to the fact that a high amount of peptide antigen
was used to prime the OVA-specific CD4  T cells in vivo.
The inability of the Clone 4 cells, undergoing activation
in response to cross-presented self-antigen, to fully down-
regulate CD62L and upregulate CD49d is consistent with
the finding that the cells undergoing tolerance are unable
to leave the lymph and enter the pancreas (29–31). Despite
their proliferation, Clone 4 cells did not accumulate in the
pancreatic LNs and could not be detected in other LNs or
at the site of expression of antigen in the pancreas. Evi-
dence was found that some cells in the pancreatic LNs were
undergoing apoptosis. Most likely the efficient clearance of
small numbers of apoptotic cells by phagocytic cells pre-
vented the detection of greater number of apoptotic cells
(32). Taken together with our previous results, which
demonstrated that tolerance induction occurs under this ac-
tivation condition (8, 13), we conclude the cells are being
deleted from the repertoire.
It is likely that lack of expression of IL-2R , which may
be a direct consequence of the absence of B7 costimulation
(33), could prevent Clone 4 cells from continued prolifera-
tion and survival. Also, CD28/B7 ligation has been shown
to enhance expression of Bcl-xL in T cells, which prevents
death induced by Fas, TCR cross-linking, or withdrawal of
IL-2 (34). Since Clone 4 cells activated by endogenous an-
tigen do not receive a costimulatory signal trough CD28,
they would not upregulate expression of this antiapoptotic
molecule. Furthermore, signaling through CD28 may be
Figure 7. Proliferation of Clone 4
cells in the pancreatic LNs of InsHA
mice is B7 co-stimulation indepen-
dent. 3   106 CFSE-labeled, puri-
fied, Thy1.1  Clone 4 CD8  T cells
were injected into InsHA recipients
that were either immunized with in-
fluenza virus or not. Half of the mice
from the two previous groups were
treated anti-B7.1 plus anti-B7.2
mAbs and the rest of the mice were
treated with rat plus hamster IgG as
isotype controls. On day 4 after
transfer, cells from the pancreatic
LNs were analyzed by FACS®. (A)
Histograms represent the amount of
CFSE label gating on lymphocytes
CD8  Thy1.1 . Percentages of cells
within each division cycle are indi-
cated in the top histograms. Data
correspond to one out of three inde-
pendent experiments with similar
results. (B) Total numbers of CD8 
Thy1.1  T cells in the pancreatic
LNs of recipient mice. Data repre-
sents the mean of all experiments
performed. (C) Cells from the pan-
creatic LNs were processed as de-
scribed in Fig. 4 to detect IFN- 
production. The percentage of lym-
phocytes CD8  Thy1.1  that are
IFN-   is represented.715 Hernandez et al.
required to express additional costimulatory molecules that
promote viability and proliferation, as has recently been de-
scribed for expression of ICOS (35). Taken together, these
results suggest that the Clone 4 T cells undergo “death by
neglect” also, referred to as passive cell death, as opposed to
AICD (36). The molecules involved in signaling apoptosis
in the InsHA mice is currently under investigation. How-
ever, preliminary experiments suggest Fas is not involved in
tolerance in InsHA mice (unpublished data). This is consis-
tent with the reports that Fas plays no role in passive cell
death (36). Interestingly, passive death has also been shown
to be involved as a mechanism of peripheral tolerance in
deletion of CD8  T cells specific for a neoantigen ex-
pressed in the liver (37). Similarly, those cells are activated
by antigen in the absence of costimulation. On the other
hand, several other studies had reported a role for Fas in the
peripheral deletion of T cells (38–40). However, in these
studies there is extensive antigen stimulation and therefore,
deletion in these other models may share features of AICD.
It has recently been shown that DCs induce CD8  T
cells proliferation by cross-presentation of endogenous
self-antigens in vivo (41). Furthermore, there is evidence
that it is the CD11c  CD8  DC subset the one responsible
for activation of CTLs through cross-presentation of anti-
gen (42). It is not yet known which type of APCs is re-
sponsible for tolerance as it occurs in InsHA mice. Future
studies will attempt to determine the precise phenotype of
the APCs involved in such tolerance. At first glance, the
finding that the mechanism by which Clone 4 T cells are
tolerized involves a lack of costimulation would seem to
counterindicate a role for DCs, as it would be expected
that any DCs that acquired HA from the islets and pre-
sented it in the pancreatic LNs should be a mature DCs
and therefore express high levels of costimulatory mole-
cules (43). However, several theories have been proposed
to explain tolerance induction by DCs. They evoke the
existence of a different subclass of DCs which is involved
in tolerance (44, 45) or a different state of activation for
DCs responsible for priming versus tolerance induction
(46). Bacterial products, viral infection, inflammatory cy-
tokines, necrotic cells, CD4  T cells activated through
CD40 or TNF-related activation-induced cytokine
expression (TRANCE)-receptor (TRANCE-R) ligation,
and activated CD8  T cells (46–48) have been shown to
induce maturation or further activate mature DCs and in-
crease expression of costimulatory molecules. A third
model that could integrate the previous two has been pro-
posed recently (49). Short lived, immature DCs may trans-
port antigen to the lymph (50), where resident lymphoid-
tolerizing DCs could phagocyte them and present antigen
to T cells. Our data cannot discriminate among these dif-
ferent hypothesis, but does indicate that regardless of the
lineage or maturation status of the tolerizing DCs, it is
likely they are not activated and therefore do not express
high levels of costimulatory molecules.
Of interest, the Clone 4 T cells activated to proliferate
by endogenous self-antigen exhibit many characteristics
that are similar to CD8  T cells undergoing homeostatic
proliferation in lymphopenic hosts (51, 52). In both cases,
activation is independent of CD28 (52). The cells under-
going homeostatic division do not upregulate CD25
or CD49d, and are unable to efficiently downregulate
CD62L. Also, within the first few weeks they did not de-
velop effector activity. However, as opposed to our results
with Clone 4 cells, CD8  T cells expanding in lym-
phopenic hosts are able to persist for a long period of
time (28, 52), whereas the Clone 4 cells undergoing pro-
liferation in response to endogenous antigen are deleted.
It has been demonstrated that homeostatic division oc-
curs in response to low affinity recognition of self-
MHC–peptide complexes (52). It is interesting to specu-
late that the seminal difference between homeostatic
division and the type of peripheral tolerance observed in
this study, may be the affinity of the TCR for self-anti-
gen. This draws obvious parallels to positive versus nega-
tive selection in the thymus.
Numerous studies have examined peripheral induction
of tolerance in vivo (53). However, it is unclear whether
the same mechanistic principles apply in the different
models. In many cases, the nature of the APC is unde-
fined. It has been shown that B7 costimulation is required
during peptide-induced anergy in CD4  T cells and tu-
mor-induced anergy in CD8  T cells (19, 54). In this last
report, CD8  T cells displayed an activated phenotype
and effector function, yet they remained in an unrespon-
sive state. Here we have shown that Clone 4 CD8  T
cells do not utilize costimulation through CD28 when
stimulated by cross-presentation of endogenous self-anti-
gen. In this condition, proliferating Clone 4 cells do not
express CD25 and presumably they do not secrete IL-2.
This is reminiscent of an anergic phenotype; however,
these cells are soon deleted, whereas anergic cells can per-
sist in vivo for long periods of time (55). Deletion of ma-
ture CD8  T cells as a consequence of self-antigen recog-
nition in the absence of costimulation has been reported
(56). In this case, T cells encounter antigen expressed on
hepatocytes that lack expression of B7 molecules. What is
surprising in our results is the fact that Clone 4 cells en-
counter antigen on professional APCs, yet no costimula-
tion is provided.
Here we have characterized a novel activation pheno-
type in CD8  T cells, which occurs after encounter with
endogenous antigen. The fate of these cells is deletion. It
was demonstrated previously that InsHA mice are tolerant
of the HA antigen in both the CD8 and CD4 compart-
ments (9). Thus, it is likely that Clone 4 cells are devoid of
cognate CD4  help in InsHA mice. We are currently eval-
uating the ability of HA-specific CD4  T cell help to pre-
vent such tolerance.
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